Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Operating Leases (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Operating Leases for 5 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Operating Leases changed 0.0% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $9.4 million for FY2025, 0.0% changed from the prior year.
  • Operating Leases for Q4 2025 was $9.4 million at Werewolf Therapeutics, up from $8.1 million in the prior quarter.
  • The five-year high for Operating Leases was $15.5 million in Q2 2022, with the low at $1.3 million in Q3 2021.
  • Average Operating Leases over 5 years is $9.9 million, with a median of $10.4 million recorded in 2024.
  • The sharpest move saw Operating Leases soared 1069.08% in 2022, then decreased 25.13% in 2023.
  • Over 5 years, Operating Leases stood at $14.6 million in 2021, then fell by 13.63% to $12.6 million in 2022, then fell by 12.76% to $11.0 million in 2023, then decreased by 14.16% to $9.4 million in 2024, then changed by 0.0% to $9.4 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $9.4 million, $8.1 million, and $8.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.